3ave: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{STRUCTURE_3ave| PDB=3ave | SCENE= }} | {{STRUCTURE_3ave| PDB=3ave | SCENE= }} | ||
===Crystal Structure of the Fucosylated Fc Fragment from Human Immunoglobulin G1=== | ===Crystal Structure of the Fucosylated Fc Fragment from Human Immunoglobulin G1=== | ||
{{ABSTRACT_PUBMED_17368483}} | |||
==Disease== | |||
[[http://www.uniprot.org/uniprot/IGHG1_HUMAN IGHG1_HUMAN]] Defects in IGHG1 are a cause of multiple myeloma (MM) [MIM:[http://omim.org/entry/254500 254500]]. MM is a malignant tumor of plasma cells usually arising in the bone marrow and characterized by diffuse involvement of the skeletal system, hyperglobulinemia, Bence-Jones proteinuria and anemia. Complications of multiple myeloma are bone pain, hypercalcemia, renal failure and spinal cord compression. The aberrant antibodies that are produced lead to impaired humoral immunity and patients have a high prevalence of infection. Amyloidosis may develop in some patients. Multiple myeloma is part of a spectrum of diseases ranging from monoclonal gammopathy of unknown significance (MGUS) to plasma cell leukemia. Note=A chromosomal aberration involving IGHG1 is found in multiple myeloma. Translocation t(11;14)(q13;q32) with the IgH locus. Translocation t(11;14)(q13;q32) with CCND1; translocation t(4;14)(p16.3;q32.3) with FGFR3; translocation t(6;14)(p25;q32) with IRF4. | |||
==About this Structure== | ==About this Structure== | ||
| Line 22: | Line 10: | ||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID:017368483</ref><references group="xtra"/> | <ref group="xtra">PMID:017368483</ref><references group="xtra"/><references/> | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Kato, K.]] | [[Category: Kato, K.]] | ||
| Line 33: | Line 21: | ||
[[Category: Shitara, K.]] | [[Category: Shitara, K.]] | ||
[[Category: Yamaguchi, Y.]] | [[Category: Yamaguchi, Y.]] | ||
[[Category: Igg1]] | |||
[[Category: Immune system]] | |||
[[Category: Immunoglobulin]] | |||
[[Category: Immunoglobulin-like beta-sandwich]] | |||
Revision as of 05:42, 25 March 2013
Crystal Structure of the Fucosylated Fc Fragment from Human Immunoglobulin G1Crystal Structure of the Fucosylated Fc Fragment from Human Immunoglobulin G1
Template:ABSTRACT PUBMED 17368483
DiseaseDisease
[IGHG1_HUMAN] Defects in IGHG1 are a cause of multiple myeloma (MM) [MIM:254500]. MM is a malignant tumor of plasma cells usually arising in the bone marrow and characterized by diffuse involvement of the skeletal system, hyperglobulinemia, Bence-Jones proteinuria and anemia. Complications of multiple myeloma are bone pain, hypercalcemia, renal failure and spinal cord compression. The aberrant antibodies that are produced lead to impaired humoral immunity and patients have a high prevalence of infection. Amyloidosis may develop in some patients. Multiple myeloma is part of a spectrum of diseases ranging from monoclonal gammopathy of unknown significance (MGUS) to plasma cell leukemia. Note=A chromosomal aberration involving IGHG1 is found in multiple myeloma. Translocation t(11;14)(q13;q32) with the IgH locus. Translocation t(11;14)(q13;q32) with CCND1; translocation t(4;14)(p16.3;q32.3) with FGFR3; translocation t(6;14)(p25;q32) with IRF4.
About this StructureAbout this Structure
3ave is a 2 chain structure with sequence from Homo sapiens. This structure supersedes the now removed PDB entry 2dtq. Full crystallographic information is available from OCA.
ReferenceReference
- ↑ Matsumiya S, Yamaguchi Y, Saito J, Nagano M, Sasakawa H, Otaki S, Satoh M, Shitara K, Kato K. Structural comparison of fucosylated and nonfucosylated Fc fragments of human immunoglobulin G1. J Mol Biol. 2007 May 4;368(3):767-79. Epub 2007 Feb 22. PMID:17368483 doi:10.1016/j.jmb.2007.02.034